Moreover, a panel of four endometriosis biomarkers (CA-125, VEGF, Annexin V, and gly-codelin/sICAM-1) showed 74–94% sensitivity and 55–75% specificity in both training and initial validation test sets [87]. This evidence concerns the gene ANXA5 and endometriosis.